In a pivotal session on 27 April 2026, the US Supreme Court engaged in a complex debate regarding the liability of pesticide manufacturers, particularly concerning glyphosate, the active ingredient in the widely used herbicide Roundup. This case, Monsanto v Durnell, has significant implications for consumer rights and the future of pesticide regulation, especially as protests erupted outside the court, advocating for accountability in the face of potential health risks.
The Heart of the Matter: Glyphosate and Public Health
The discussions centred on glyphosate, a chemical linked to cancer in several studies and classified as a probable human carcinogen by the World Health Organization in 2015. Bayer, which acquired Monsanto, faces over 100,000 lawsuits from individuals diagnosed with non-Hodgkin lymphoma, alleging their illnesses stem from exposure to glyphosate-based products. The company has already disbursed billions in settlements and jury awards, yet it stands firm in its assertion that its products are safe.
At the core of the Supreme Court’s deliberation is whether the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) shields Monsanto from liability for not providing cancer warnings, given the Environmental Protection Agency (EPA) has not mandated such notifications. Bayer contends that as long as the EPA maintains that glyphosate is “unlikely” to be carcinogenic, it cannot be held liable for failing to warn consumers of potential risks.
Legal Arguments and Court Dynamics
During the proceedings, Paul Clement, representing Bayer, argued that FIFRA’s provisions prohibit pesticide manufacturers from altering safety labels without EPA approval. He stressed that Congress intended to establish a consistent regulatory environment for farmers relying on these products. Clement stated, “Ignoring Congress’ clear direction would open the door for crippling liability and undermine the interests of farmers who depend on federally registered pesticides for their livelihood.”
Contrastingly, attorney Ashley Keller, representing the plaintiffs, challenged the notion that FIFRA grants blanket immunity to pesticide makers. He pointed out the flaws in the EPA’s registration process, highlighting that the agency has failed to conduct timely reviews of glyphosate, which could allow harmful products to evade scrutiny. Keller also noted that a 2022 ruling by the Ninth Circuit Court of Appeals vacated the EPA’s findings on glyphosate due to inadequate adherence to established cancer risk assessment guidelines.
The justices posed tough questions to both sides, particularly probing the implications of new scientific evidence emerging between EPA reviews. The exchanges suggested a divide, with the court’s liberal justices appearing sceptical of Monsanto’s arguments, while the opinions of the conservative justices remained more ambiguous.
Public Outcry and the Call for Accountability
Outside the Supreme Court, demonstrators rallied under the banner of the Maha movement, vehemently opposing the Trump administration’s backing of Monsanto. They carried signs proclaiming messages like “people over poison” and “Roundup the guilty,” voicing their demands for corporate accountability. Zen Honeycutt, founder of Moms Across America, articulated the urgency of the situation: “It’s crucial right now to show up and let not just the supreme court know but also our legislative branch and our executive branch that we will not stand for being poisoned any more.”
The gathering also attracted notable lawmakers, including Chellie Pingree, a Democratic representative from Maine, who underscored the bipartisan concern surrounding pesticide safety. “To have so many people show up from all over the country and to have so many Republicans and Democrats united about keeping poisons out of our food is a big day,” she remarked.
Legislative Context and Future Implications
The Supreme Court’s deliberation comes at a critical time as the US House of Representatives reviews the Farm Bill, which includes provisions that could shield chemical manufacturers from lawsuits. An amendment proposed by Pingree and Republican representative Thomas Massie aims to remove such protections, highlighting the growing legislative push for greater accountability in the agricultural sector.
A decision from the Supreme Court is anticipated this summer, which could significantly alter the landscape of pesticide regulation and consumer rights in the United States.
Why it Matters
The outcome of this case could set a precedent that impacts not only Bayer and Monsanto but also the entire pesticide industry. As public awareness of health risks associated with chemical exposure grows, the court’s ruling may either bolster consumer protections or reinforce corporate immunity, shaping the future of public health and environmental safety in America. The implications are profound, as they touch upon the delicate balance between agricultural practices and the health of the population, calling into question the integrity of regulatory oversight in an era where accountability is increasingly demanded by the public.
